hrp0097fc1.6 | Adrenals and HPA Axis | ESPE2023
van der Zwan Y.G.
, Schrӧder M.
, Stikkelbroeck N.M.M.L.
, Reisch N.
, Falhammar H.
, Roeleveld N.
, Claahsen-van der Grinten H.L.
Background: Adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD) develop an adverse metabolic and cardiovascular risk profile. Both over- and undertreatment with glucocorticoids are associated with these adverse metabolic effects. There is limited data available of changes in cardiovascular parameters during lifetime.Objective: This study aimed to evaluate unfavorable changes in cardiovascu...